MDx’s central lab and transplant center partnersNew hospital-based data seeks to further differentiate pending kitted assay ...

The Business Research Company’s Molecular Diagnostics For Sexually Transmitted Diseases Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 ...

Molecular diagnostics are well-established in clinical medicine. Nonetheless, the markets for these tests remain one of the most attractive growth opportunities in the in vitro diagnostics industry.

Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...

Antimicrobial resistance (AMR) represents one of the most pressing global health challenges of the 21st century, threatening the effectiveness of treatments and burdening healthcare systems worldwide.

The global Molecular Diagnostics Market, valued at US$18.29 billion in 2024, stood at US$19.48 billion in 2025 and is projected to advance at ...

Insight Molecular Diagnostics (IMDX) is actively enrolling patients in its clinical trial to assess GraftAssureDx and that last week, it enrolled ...

The Empowered Patient Podcast with Karen Jagoda recently featured Andrea James, Chief Financial Officer of Insight Molecular ...

Imagine a future where disease diagnosis is not only incredibly precise but also lightning-fast, revolutionizing healthcare as we know it. QUASR Diagnostics is taking center stage and leading the ...

Insight Molecular Diagnostics (IMDX) announced a strategic update and novel registry that will serve to gather real-world data on patient ...